𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preparation and Characterization of Biodegradable Microspheres Containing Hepatitis B Surface Antigen

✍ Scribed by Shaobing Zhou; Xueyan Liao; Zhenglun Liang; Xiaohong Li; Xianmo Deng; Heming Li


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
161 KB
Volume
4
Category
Article
ISSN
1616-5187

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Summary: Poly‐DL‐lactide‐poly(ethylene glycol) (PELA) microspheres containing Hepatitis B surface antigen (HBsAg) were elaborated by a solvent extraction method based on the formation of a double water/oil/water (w/o/w) emulsion. Microspheres were characterized in terms of morphology, size and size distribution, encapsulation efficiency, and the efficiency of microsphere formation (EMF). Transmission electron microscopy (TEM) and polyacrylamide gel electrophoresis (PAGE) were used to investigate the structural integrality of HBsAg encapsulated in PELA microspheres. The release profile was investigated by the measurement of antigen present in the release medium at various intervals. The PELA‐10 microspheres displayed the highest antigen encapsulation efficiency (about 80%), and antigen molecules could be stabilized in the PELA‐10 microspheres during the preparation process. It suggested that the PELA microspheres had a great potential as a new polymer adjuvant for HBsAg.

The release of Hepatitis B surface antigen from poly‐DL‐lactide‐poly(ethylene glycol) microspheres.

imageThe release of Hepatitis B surface antigen from poly‐DL‐lactide‐poly(ethylene glycol) microspheres.


📜 SIMILAR VOLUMES


Preparation and characterization of inte
✍ Shaobing Zhou; Jing Sun; Lin Sun; Yanqin Dai; Liping Liu; Xiaohong Li; Jianxin W 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

## Abstract In this work, magnetite (Fe~3~O~4~) nanoparticles with an average size 10 nm modified by sodium oleate were prepared by the modified controlled chemical coprecipitation method, which can be well dispersed in water and linked well with protein molecules because of the presence of —COOH o

Association of concurrent hepatitis B su
✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

The structure of hepatitis B surface ant
✍ Darrell L. Peterson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

Hepatitis B virus infects about 200 million people worldwide yearly. The consequences of the infection range from mild, sew-limiting hepatitis with full recovery and immunity to chronic infection with liver disease of varying severity, including fulminant hepatitis and death. Alternatively, individu

Localization of hepatitis B surface anti
✍ Colette Jolivet-Reynaud; Mylène Lésenéchal; Barbara O'Donnell; Laurence Becquart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract Small hepatitis B surface antigen (HBsAg) is considered to be the best marker for the diagnosis of Hepatitis B virus infection. However, HBsAg variants with mutations within the “a” determinant may be poorly or not detected by diagnostic assays. Three anti‐HBsAg monoclonal antibodies (6

Quantitative hepatitis B surface antigen
✍ Jung Min Lee; Sang Hoon Ahn; Hyon Suk Kim; Hana Park; Hye Young Chang; Do Young 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Quantitative hepatitis B surface antigen (qHBsAg) and quantitative hepatitis B e antigen (qHBeAg) titers are emerging as useful tools for measuring viral loads and for predicting the virological response (VR) and serological response (SR) to pegylated interferon therapy. However, the clinical utilit